Page 10 - Terminology-Clinical-Research
P. 10

status of a patient or subject.                        including their toxicology, safety, pharmacodynamics,
                                                               and pharmacokinetics (ADME- absorption, distribution,
        Clinical development plan: A document that describes   metabolism, and excretion).
        the collection of clinical studies that are to be performed in
        sequence, or in parallel, with a particular active substance,   Clinical protocol: See Protocol.
        device, procedure, or treatment strategy, typically with
        the intention of submitting them as part of an application   Clinical Research Associate (CRA): Person employed
        for a marketing authorization. Note: The plan should have   by the study sponsor or clinical research coordinator to
        appropriate decision points and allow modification as   monitor a clinical trial at one or more participating sites.
        knowledge accumulates.                                 The CRA is responsible for ensuring all clinical studies are
                                                               conducted according to study protocol, within regulations
        Clinical document architecture: Specification for the   and ICH guidelines.
        structure and semantics of “clinical documents” for the
        purpose of exchange.                                   Clinical research and development: The testing of a drug
                                                               compound in humans primarily done to determine its safety
        Clinical document: A documentation of clinical         and pharmacological effectiveness. Clinical development is
        observations and services. Note: An electronic document   done in phases, which progress from very tightly controlled
        should incorporate the following characteristics:      dosing of a small number of subjects to less tightly
        persistence, stewardship, potential for authentication,   controlled studies involving large numbers of patients.
        wholeness, and human readability.
                                                               Clinical Research Associate (CRA): Person employed
        Clinical efficacy: Power or capacity to produce a desired   by a sponsor or by a contract research organization acting
        effect (i.e., appropriate pharmacological activity in a   on a sponsor’s behalf, who monitors the progress of
        specified indication) in humans.                       investigator sites participating in a clinical study. At some
                                                               sites (primarily in academic settings), clinical research
        Clinical encounter: Contact between subject/patient    coordinators are called CRAs.
        and healthcare practitioner/researcher, during which an
        assessment or activity is performed. Contact may be    Clinical Research Coordinator (CRC): Person who
        physical or virtual.                                   handles most of the administrative responsibilities of a
                                                               clinical trial on behalf of a site investigator, acts as liaison
        Clinical genomics - clinical trials impact: Clinical   between investigative site and sponsor, and reviews all
        genomics is the application of large-scale, high throughput   data and records before a monitor’s visit. Synonyms:
        genomics technologies in clinical settings, such as clinical   trial coordinator, study coordinator, research coordinator,
        trials or primary care of patients. Clinical genomics   clinical coordinator, research nurse, protocol nurse.
        promises to allow a molecular understanding of disease
        and drug response, with benefits in all areas of medicine.   Clinical Research Organization (CRO): An organization
        Note: Contributing to the growth of genomics, in 2005   that conducts all or some of the clinical research involved
        the FDA issued guidelines for applications of genomics in   in the drug or product development process on behalf of
        drug development, with the stated hope that genomics will   pharmaceutical research companies.
        improve the safety and effectiveness of medicines. Given
        this mandate, clinical genomics applications appear to have   Clinical significance: Change in a subject’s clinical
        crossed a threshold with the recent approval of several   condition regarded as important whether or not due to
        clinical genomics products.                            the test intervention. Note: Some statistically significant
                                                               changes (in blood tests, for example) have no clinical
        Clinical investigation: See Clinical trial, Clinical study.   significance. The criterion or criteria for clinical
        Note: Increased usage of investigation or study in the US   significance should be stated in the protocol. The term
        rather than “trial,” may reflect the appearance of the term in  “clinical significance” is not advisable unless operationally
        FDA regulations concerning clinical research activities.   defined.

        Clinical Investigator: A medical researcher in charge of   Clinical study (trial) report: A written description of a
        carrying out a clinical trial’s protocol.              study of any therapeutic, prophylactic, or diagnostic agent
                                                               conducted in human subjects, in which the clinical and
        Clinical pharmacology: Science that deals with the     statistical description, presentations, and analysis are fully
        characteristics, effects, properties, reactions, and uses   integrated into a single report.
        of drugs, particularly their therapeutic value in humans,

         10                                          AlphaScienceLabs.com
   5   6   7   8   9   10   11   12   13   14   15